The Ensign Group (ENSG) Gets a Buy from Oppenheimer
Oppenheimer analyst maintained a Buy rating on The Ensign Group today and set a price target of $210.00.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
In addition to Oppenheimer, The Ensign Group also received a Buy from TipRanks – xAI’s xAi Medical – Care Facilities in a report issued today. However, on the same day, TipRanks – Anthropic downgraded The Ensign Group (NASDAQ: ENSG) to a Hold.
Based on The Ensign Group’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.3 billion and a net profit of $83.84 million. In comparison, last year the company earned a revenue of $1.08 billion and had a net profit of $78.44 million
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.